HEART FAILURE WITH MIDRANGE EJECTION FRACTION

HEART FAILURE WITH MIDRANGE EJECTION FRACTION was reported 59 times

HEART FAILURE WITH MIDRANGE EJECTION FRACTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 HER2/neu Receptor Antagonist [EPC] 20 0.0003
1 Antihypoglycemic Agent [EPC] 1 0.0002
2 Topoisomerase Inhibitor [EPC] 10 0.0001
3 Sigma-1 Agonist [EPC] 1 0.0001
4 Alkylating Drug [EPC] 22 0.0001
5 Alkaloid [EPC] 2 0.0001
6 Microtubule Inhibitor [EPC] 11 0.0001
7 Anticholinergic [EPC] 1 0.0001
8 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
9 Platinum-based Drug [EPC] 10 0.0000
10 Phenothiazine [EPC] 1 0.0000
11 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
12 Arteriolar Vasodilator [EPC] 2 0.0000
13 Aromatase Inhibitor [EPC] 2 0.0000
14 Factor Xa Inhibitor [EPC] 4 0.0000
15 Androgen Receptor Inhibitor [EPC] 1 0.0000
16 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
17 Catecholamine [EPC] 1 0.0000
18 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
19 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
20 Partial Opioid Agonist [EPC] 1 0.0000
21 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
22 Vitamin B12 [EPC] 3 0.0000
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
24 Loop Diuretic [EPC] 4 0.0000
25 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
26 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
27 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
28 Vitamin C [EPC] 3 0.0000
29 Platelet Aggregation Inhibitor [EPC] 4 0.0000
30 Aldosterone Antagonist [EPC] 1 0.0000
31 Janus Kinase Inhibitor [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
33 RANK Ligand Inhibitor [EPC] 1 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Osmotic Laxative [EPC] 1 0.0000
36 Vitamin D [EPC] 1 0.0000
37 beta-Adrenergic Blocker [EPC] 1 0.0000
38 Corticosteroid [EPC] 3 0.0000
39 Insulin Analog [EPC] 1 0.0000
40 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
41 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
42 Proton Pump Inhibitor [EPC] 1 0.0000